Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Cash from Operations (2016 - 2025)

Creative Medical Technology Holdings has reported Cash from Operations over the past 15 years, most recently at 1937554.0 for Q4 2025.

  • Quarterly Cash from Operations rose 0.61% to 1937554.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 5856445.0 through Dec 2025, down 10.47% year-over-year, with the annual reading at 5856445.0 for FY2025, 10.47% down from the prior year.
  • Cash from Operations was 1937554.0 for Q4 2025 at Creative Medical Technology Holdings, down from 1168609.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 222139.0 in Q2 2021 and troughed at 3841642.0 in Q1 2023.
  • The 5-year median for Cash from Operations is 1236566.0 (2023), against an average of 1459918.5.
  • Biggest five-year swings in Cash from Operations: tumbled 2137.93% in 2021 and later surged 76.65% in 2024.
  • Tracing CELZ's Cash from Operations over 5 years: stood at 1161336.0 in 2021, then tumbled by 209.23% to 3591234.0 in 2022, then soared by 47.23% to 1894983.0 in 2023, then dropped by 2.88% to 1949536.0 in 2024, then grew by 0.61% to 1937554.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 1937554.0, 1168609.0, and 1158747.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.